摘要
最近,美国心脏病学会(ACC)/美国心脏协会(AHA)/美国心衰学会(HFSA)更新发布的2022年心力衰竭(心衰)管理指南(下称新指南),立足最新循证医学证据,在心衰分类、慢性心衰药物治疗以及特殊人群心衰诊疗方面均有重要更新。本文将从心衰的定义、分类及诊断评估方面,对新指南及其重要更新进行解读。
The American College of Cardiology(ACC)/American Heart Association(AHA)/Heart Failure Society of America(HFSA) 2022 guidelines for the management of heart failure was recently updated. Based on the latest evidence-based medical evidence, the new guidelines contain important updates in the classification of heart failure, pharmacological treatment of chronic heart failure and the management of heart failure in special populations. This articlel explains the new guidelines and their important updates in terms of definition,classification and diagnostic assessment of heart failure.
作者
王华
李莹莹
WANG Hua;LI Ying-ying(Department of Cardiology,Beijing Hospital National Center of Gerontology Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing 100730,China)
出处
《中国心血管病研究》
CAS
2022年第6期481-486,共6页
Chinese Journal of Cardiovascular Research
关键词
心力衰竭
定义
分类
诊断
评估
Heart failure
Definition
Classification
Diagnosis
Evaluation
